| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.37 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |